Aarnio, Richard http://orcid.org/0000-0002-6420-514X
Kirjavainen, Anna
Rajander, Johan
Forsback, Sarita
Kalliokoski, Kari
Nuutila, Pirjo
Milicevic, Zvonko
Coskun, Tamer
Haupt, Axel
Laitinen, Iina
Haaparanta-Solin, Merja
Funding for this research was provided by:
Eli Lilly and Company (Eli Lilly and Company)
Article History
Received: 25 April 2024
Accepted: 28 May 2024
First Online: 13 June 2024
Declarations
:
: The study was performed in accordance with the ethical principles that have their origin in the Declaration of Helsinki. The study was approved by the internal review board and approval was granted by the ethical committee of the Hospital District of South-Western Finland. The study was registered in the NIH clinicaltrials.gov (NCT05132335) and EudraCT (No: 2020-005211-48). Informed consent was obtained from all individual participants included in the study.
: Written informed consent for publication was obtained.
: Employments at the time of study: IL by Antaros Medical AB, Mölndal, Sweden; TC, ZM and AH by Eli Lilly and Company. The other authors declare that they have no competing interests.